µÚËľüÒ½´óѧ1998ÄêÃâÒßѧ£¨²©Ê¿£© s*WfRY*=V
fJV VW
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© ' .<"jZ
1.Co-stimulators (or co-stimulating molecules) 73`UTXvWU
2.NK-kB q|2C>{8
3.Immunoglobulin superfamily 5X-(@GwN
4.antigen-presenting cell (APC) [uHI
6Q#
5.death domain 2p ,6=8^v
6.CCR and CXCR /_(Dq8^g@
7.Lectin (or mitogen) %s yBm
8.Clusters of differentiation, CD) p}z0(lQ*~
9.B7 family 1 j8,Zrg1
10.Cytotoxic T lymphocyte, CTL) S_6
;e|
11.IL-15 and IL-15 receptor (IL-15R) NQD b;5:
12.MHC restriction ZQ/5]]}3y
13.Affinity-chromatography df\>-Hl
14.Cyctosprin A, CsA hn.fX:}
15.Antibody-dependent cell-mediated cytotoxicity, ADCC) aQ.
\!&U
WGn1pW
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© Q0-~&e_'
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 `rV,<
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ V5MbWXgR
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌØµã¡£ h,g~J-x`|
#>'0C6Xn
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© Rz]bCiD3
B
m|[Hhw=f
ÃâÒßѧרҵ£º kOO2 ?L|Z
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ zx*f*L,6F
x1h!_^(QfF
Ïû»¯ÄÚ¿Æ£º k,,}N9
2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ %LyB~X
[<hiOB
ѪҺ²¡Ñ§×¨Òµ£º
8:MYeE5
3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿